Accuray's European AERO Academy Meeting: Innovation and Safety in the Field of Advanced Radiotherapy - Patients Come First

Sunnyvale, Caliornia (ots/PRNewswire) -

2018 Accuray Conference Focused on Innovative Approaches for
Advancing Patient Care, from Curative Treatment to Oligometastases
and Palliation

Accuray Incorporated (NASDAQ: ARAY) announced today highlights
from its 2018 European AERO(TM) (https://accurayexchange.com/)
(Accuray Exchange in Radiation Oncology) Academy conference held in
Lisbon, Portugal on January 26th and 27th.

"Accuray is firmly committed to providing our customers with
access to clinical thought leadership and forums that encourage
treatment innovation. The AERO Academy events, both in the US and in
Europe, are a driving force behind our patient-first philosophy,"
said Joshua H. Levine, President and Chief Executive Officer at
Accuray. "Events like this allow our leadership team to obtain first
hand insights into our radiation oncologists' and physicists' needs
and their views on how to advance and optimize patient treatment."

These events, which aim to provide an update on current treatment
options in the field of advanced radiotherapy, offer a unique
opportunity for radiation oncologists and medical physicists from
around the world to gather in an exciting educational environment. At
the Lisbon event, industry experts engaged in conversations on a
broad range of topics including:

- The value of localized radiation therapy for organ-confined tumors,
locally advanced tumors and metastatic tumors
- Advances in radiation therapy, from efficacy and toxicity to
convenience and impact on patients' quality of life
- Progress in re-irradiation and adaptive radiation therapy
techniques
- The optimal approach for treating tumors, based on current
knowledge and unique patient attributes

"It was an honor to introduce and participate in this year's AERO
Academy conference. Patients were truly at the heart of every
conversation as we discussed how to innovatively use radiation
therapy to deliver highly effective and safe outcomes," said Barbara
A. Jereczek-Fossa, M.D., Ph.D., Chair of the Division of Radiotherapy
at the European Institute of Oncology and Associate Professor of
Radiation Oncology at the University of Milan, Italy. "The conference
sessions enabled us to focus on topics that have the potential to
positively impact our practice today and in the future. The scope and
quality of the scientific exchange resulted in another great
instructional meeting."

"We are proud to host this biennial conference dedicated to
precision radiation therapy. We believe collaborations with
clinicians and scientists are the key to successfully advancing the
way radiation therapy is delivered, and ensuring that patients
receive the treatment best suited to their particular situation,"
said Fabienne Hirigoyenberry-Lanson, Ph.D., Vice President Global
Medical and Scientific Affairs at Accuray. "We are convinced that the
sharing of clinical improvements and technological advancements, as
well as peer-to-peer discussion on treatment experiences, encourage
innovation, better results and safety in patient care."

About Accuray Exchange in Radiation Oncology (AERO(TM))

AERO includes CyberKnife®
(http://www.accuray.com/product/cyberknife), Radixact(TM)
(http://www.accuray.com/product/radixact) and TomoTherapy®
(http://www.accuray.com/product/tomotherapy) System users dedicated
to advancing patient care through worldwide clinical and technical
partnerships. The AERO community mission is to provide a global forum
for the clinical exchange of information between clinicians and
physicists for the purpose of setting a new standard in patient care
and safety across treatments in the fields of SRS/SBRT, IMRT, IGRT
and conventional radiation therapy. Membership to AERO is free and
open to all users of the CyberKnife, Radixact and TomoTherapy
Systems.

About Accuray

Accuray Incorporated (Nasdaq: ARAY) is a radiation oncology
company that develops, manufactures and sells precise, innovative
treatment solutions that set the standard of care with the aim of
helping patients live longer, better lives. The company's
leading-edge technologies deliver the full range of radiation therapy
and radiosurgery treatments. For more information, please visit
http://www.accuray.com or follow us on Facebook
(https://www.facebook.com/AccurayIncorporated/), LinkedIn
(https://www.linkedin.com/company/accuray), Twitter
(https://twitter.com/accuray) and YouTube
(https://www.youtube.com/user/AccurayIncorporated).

ots Originaltext: Accuray
Im Internet recherchierbar: http://www.presseportal.de

Contact:
Sancie Nakarat
Accuray
+33-(0)6-81-36-84-34
snakarat@accuray.com

Original-Content von: Accuray, übermittelt durch news aktuell